Topic guide

Diabetes and metabolic health

Evidence checks about diabetes, glucose, insulin resistance, metabolic syndrome, CGMs, drugs, diet and prevention claims.

What to watch for

Common ways headlines can go too far

  • Glucose or insulin markers framed as long-term disease prevention
  • Drug effects mixed with lifestyle claims
  • Weight change treated as a proxy for all metabolic outcomes

Diabetes and metabolic-health stories often mix glucose markers, weight change, drug effects, diet advice and long-term disease risk without separating outcomes clearly.

Common hype patterns

  • Glucose or insulin markers framed as long-term disease prevention.
  • Weight-loss signals treated as a proxy for all metabolic outcomes.
  • Continuous glucose monitor findings generalised to broad consumer advice.
  • Drug and lifestyle effects mixed without clear comparator context.

Questions to ask before trusting the headline

  • Was the claim tested in people, or only in cells, animals or models?
  • Is the outcome something patients notice, or only a surrogate marker?
  • Does the headline distinguish association from causation?
  • Are absolute risks, comparators and uncertainty shown clearly?
  • Would the finding change real-world behaviour, or is it mainly hypothesis-generating?

How deHype.io reads this topic

deHype.io separates the public claim from the underlying evidence. The aim is not to dismiss early science, but to show whether the headline has kept the finding in proportion.

Seen a headline in this topic? Paste the link and get a deHype evidence check.
Check a metabolic-health headline